Research Article
Adherence to Typical Antipsychotics among Patients with Schizophrenia in Uganda: A Cross-Sectional Study
Table 5
Factors associated with nonadherence to typical antipsychotic medications among patients with schizophrenia.
| Variable | Bivariate logistic regression | Multivariate logistic regression | Crude odds ratio (95% confidence interval) | value | Adjusted odds ratio (95% confidence interval) | value |
| Age | 0.99 (0.95–1.03) | 0.724 | | | Sex | Female | 1 | | | | Male | 0.67 (0.26–1.72) | 0.406 | | | Marital status | Single | 1 | | | | Married/cohabiting | 1.13 (0.36–3.52) | 0.828 | | | Separated/divorced | 0.88 (0.27–2.89) | 0.836 | | | Level of education | None | Omitted | | Omitted | | Primary | 8.21 (1.00–67.55) | 0.050 | 7.36 (0.56–95.92) | 0.127 | Secondary | 10.06 (1.23–82.33) | 0.031 | 10.99 (0.79–152.17) | 0.074 | Tertiary | 1 (ref) | | 1 | | Area residence | Rural | 1 | | | | Urban | 0.94 (0.37–2.37) | 0.892 | | | Poverty line | Above | 1 | | 1 | | Below | 1.96 (0.77–4.95) | 0.157 | 7.15 (1.39–36.67) | 0.018 | Substance use | No | 1 | | | | Yes | 0.64 (0.20–2.06) | 0.458 | | | Distance from the hospital | 1.02 (0.99–1.03) | 0.108 | 1.01 (0.98–1.04) | 0.521 | Presence of a comorbidity | No | 1 | | 1 | | Ye | 1.78 (0.61–5.20) | 0.293 | 2.05 (0.40–10.64) | 0.391 | Insight for psychosis | Good | 1 | | | | Poor | 0.85 (0.29–2.51) | 0.772 | | | Attitude towards typical antipsychotic | Negative | 1 | | | | Positive | 1.40 (0.48–4.11) | 0.538 | | | Duration of treatment (in years) | 0.97 (0.91–1.04) | 0.456 | | | Satisfaction with medication | 1.23 (0.77–197) | 0.379 | | | Burdened by the number of pills | No | 1 | | | | Yes | 1.08 (0.42–2.81) | 0.868 | | | Number of pills | 0.79 (0.60–1.04) | 0.091 | 0.85 (0.52–1.38) | 0.511 | Frequency of daily drug taking | Once | 1 | | 1 | | Twice | 0.56 (0.21–1.52) | 0.257 | 0.43 (0.08–2.18) | 0.308 | Three times | 0.27 (0.03–2.28) | 0.232 | 0.36 (0.02–7.32) | 0.507 | Four or more times | 3.85 (0.22–65.71) | 0.352 | 4.18 (0.08–228.96) | 0.483 | Frequency of drug stoke out at the facility for patients’ medications | Never | 1 | | | | Rarely | 2.12 (0.20–21.88) | 0.529 | | | Sometimes | 1.64 (0.19–14.37) | 0.657 | | | Often | 1.42 (0.13–15.64) | 0.774 | | | Always | 2.77 (0.26–29.04) | 0.396 | | | Level of social support from family and friends | 0.87 (0.56–1.37) | 0.559 | | | Satisfaction with health workers’ explanations of drug use and side effects | 0.91 (0.65–1.28) | 0.595 | | | Stop medications due to religious or cultural beliefs | No | 1 | | | | Yes | 1.27 (0.49–3.31) | 0.620 | | | Loss of energy or drive | No | 1 | | 1 | | Yes | 0.22 (0.09–0.59) | 0.002 | 0.15 (0.03–0.81) | 0.028 | Feeling unmotivated | No | 1 | | 1 | | Yes | 0.41 (0.16–1.09) | 0.073 | 2.18 (0.35–13.47) | 0.401 | Day time sedation | No | 1 | | 1 | | Yes | 0.59 (0.24–1.49) | 0.266 | 1.59 (0.36–6.99) | 0.535 | Too much sleep | No | 1 | | | | Yes | 0.84 (0.33–2.13) | 0.715 | | | Muscle too stiff | No | 1 | | | | Yes | 1.42 (0.52–3.83) | 0.492 | | | Shaking | No | 1 | | | | Yes | 0.61 (0.22–1.68) | 0.339 | | | Jittery | No | 1 | | | | Yes | 0.63 (0.21–1.84) | 0.397 | | | Akathisia | No | 1 | | 1 | | Yes | 0.48 (0.13–1.74) | 0.264 | 0.68 (0.12–3.94) | 0.671 | Trouble waking up | No | 1 | | | | Yes | 0.95 (0.38–2.36) | 0.909 | | | Vision problems | No | 1 | | 1 | | Yes | 0.49 0.16–1.57) | 0.233 | 0.42 (0.08–2.06) | 0.282 | Dry mouth | No | 1 | | | | Yes | 0.88 (0.33–2.35) | 0.807 | | | Drooling of saliva | No | 1 | | | | Yes | 0.89 (0.24–3.34) | 0.865 | | | Memory problems | No | 1 | | | | Yes | 0.94 (0.38–2.36) | 0.901 | | | Constipation | No | 1 | | 1 | | Yes | 1.73 (0.66–4.57) | 0.265 | 2.45 (0.59–10.13) | 0.217 | Weight changes | Decrease | 0.29 (0.06–1.54) | 0.148 | 1.34 (0.18–9.85) | 0.772 | Increase | 0.60 (0.22–1.64) | 0.318 | 6.66 (0.73–60.51) | 0.092 | No change | 1 | | 1 | | Sexual arousal problems | No | 1 | | | | Yes | 1.06 (0.42–2.65) | 0.901 | | | Menstrual changes | No | 1 | | 1 | | Yes | 2.27 (0.77–6.67) | 0.135 | 1.22 (0.26–5.60) | 0.798 | Total number of side effects experienced | 0.89 (0.76–1.04) | 0.138 | | |
|
|